Member Info for technick

if it was in lieu of fees should this not have formed part of a separate RNS? If it has been on the open market then they must have been buying pretty much all of the shares - an extra 8% is a lot to buy over a short period?

With the expected news this will recover, the last raise was done at 9p less than 2 months ago, its why there was a drop from the 13-15p high. A lot of traders have just sold into the drop to make a quick profit and waiting for the level to buy back in and repeat. Fundamentals are strong, product portfolio strong and getting stronger with FDA and sales and partnerships will now follow.

Pre-FDA the business issued a business development and sales agreement with CorTech for IB software's suite of quantitative and automated tools (StoneChecker, IB Neuro and IB Delta).

Subsequent to the FDA announcement they issued the statement "Relationships with key strategic partners for StoneChecker have been cultivated for some time, including discussions with companies that are CT technology providers, suppliers of lithotripsy equipment and companies specializing in the kidney sector which sell directly to kidney specialists. These discussions are continuing, as we evaluate how best to optimize the commercial opportunities provided by last week's FDA clearance."

It loos as though a number of sales avenues will be explored. If a tie up with an equipment manufacturer does materialise then this should have minimum sales volumes linked to those equipment sales. That could quite quickly change the sales picture here.

If new commercial contracts come through this will recover, if they don't it won't. Looking at the history of DS you have to believe one of these outcomes is more likely than the other. LTH, sold some and still holding the remainder. The fundamentals continue to grow stronger, the market is interesting, and the Company has FDA approved software.

Ramping / de-ramping are different sides of the same coin. Equally as bad as each other because they have the intention of creating either a false rise or a false fall. People can loose either way depending on where they bought in.

I may be wrong but it also seems that very little is owned by PIs, mostly held be institutional investors one way or an other. That would be interesting when more come in to buy. I agree we need more PI coverage on twitter...

Agreed. I'm not convinced these are sellers in the market, nobody with shares needs to sell £50 or £500, so are these low volumes of stock the MM have on their books until someone puts a larger sell order in to replenish or start the trading cycle? Just thinking out loud!

Yes true. Value is value so at some point it will be reflected in the share price and as you say it keeps the stupid day trading mob out, but a spread of 1/3rd is rather significant...

cheers guys. Good luck to all the LTHs, I am confident this will come good. Anyone who benefited from dumping shares and releasing market sensitive information either directly or indirectly I suspect won't dare buy in again and repeat as there are too many eyes on them. I hope the raise will be at 0.2p and we see some positive impact when our further project announcements materialise in the coming weeks and months. From all of the knowledgeable people I've listened to the expectation is this should level out between 0.6p and 1p. Value is the value regardless of the manipulation, it will eventually get there if the fundamentals are there. If not, of course it won't, but it does look more positive than negative at this point in time in my opinion.

... the drop today happened before 8:30, since then you could not buy at the low. Only those who could buy before trading hours got in here... am I being cynical or simply showing my lack of knowledge?

I which the MMs would narrow the spread, either way is fine but at the moment they just kill any trading....

Hi Troy, yes I think that's fair. It supports the brokers view on share price so hopefully with more momentum and market knowledge the share price will recover. I'd prefer to see steady uplift over the next 12-24 months rather than a runaway bandwagon!

I'm not convinced that institutions would leak the information in the same way that DB would not leak the information. It's simply not worth the risk. However, some larger non-institutional investors may have been passed the document and asked if they would like to take part in the round, not uncommon... Whoever it was needs to be identified.

Does anyone know what sort of price the test will be set at? In the blurb over the past few weeks they suggested 90k infants per year in the UK. The frequency was 1:500 and a £50k cost for deafness treatment over their lifetime so 180 per year is £9m cost to the NHS for not testing. If the test was £20 then testing 90k infants per year would cost £1.8m saving £7.2m per year apart from the better standard of patient care. And if the UK is 1% of the global market, call it 10% because its the home market, then the potential is £18m per annum for this test. Does anyone disagree? What have I missed?

news this morning, I think this will represent a really good commercial opportunity for the company, hopefully they’ll publicise it widely!

for news this week and for the so getting back on track

It was the same for Reabold if you remember, the placing presentation found its way onto the forums before the announcement... it shouldn’t happen and people who do it should be investigated IMO. The Company executives would have no control over it.

Would this not be illegal and should it not be investigated if true?

I guess all investments are risky, you invest in company’s like IQAI because they have the potential to invest early and benefit from the increasing value as the business grows. Time will tell. You’ve sold and have your car, good on new, I sold my original investment and still own shares because I believe in the long term prospects. I’m not a day trader or a shorter. I’m sure short term you’re correct. Before news having already risen significantly this will drift lower. When news drops it will rise but probably not to the same extent as now valuation will be based on delivery and sales figures. For me personally this is an 18 month investment, I’m not smart enough to be able to predict the top and bottom... I just look at the fundamentals and the long term prospects and to date I like the way DS does small raises on news, minimises dilution and demonstrates positive progress.

News will come here, the foundations are sound and it’s a hot area. Personally I think it’s a 18 month process to see significant sales, DS has already gone on record to say the sales cycle is 12 months but has gone from a $35k ticket item to a $100k ticket item. I’m interested to see how that trajectory grows especially as more diagnostic elements are added.